This video is under embargo. Please login to access this video.
Caption
Video summarizing the challenges associated with injectable insulin formulations often used for management of type 1 diabetes, our innovative approach and solution, and the exciting results we present in our paper. This material relates to a paper that appeared in the Jul. 1, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by J.L. Mann at Stanford University in Stanford, CA; and colleagues was titled, "An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients."
Credit
Professor Eric Appel, Assistant Professor of Materials Science & Engineering, Stanford University; Joseph Mann, PhD Candidate in Materials Science & Engineering, Stanford University; Caitlin Maikawa, PhD Candidate in Bioengineering, Stanford University
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.